Granahan Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,148,970
Closed -$5.97M 238
2016
Q4
$5.97M Buy
1,148,970
+120,050
+12% +$564K 0.21% 139
2016
Q3
$4.8M Buy
1,028,920
+27,560
+3% +$129K 0.16% 153
2016
Q2
$3.94M Sell
1,001,360
-27,100
-3% -$101K 0.14% 160
2016
Q1
$3.19M Buy
1,028,460
+50,142
+5% +$168K 0.12% 179
2015
Q4
$4.47M Buy
978,318
+473,168
+94% +$2.24M 0.15% 174
2015
Q3
$2.38M Sell
505,150
-29,300
-5% -$189K 0.07% 216
2015
Q2
$3.83M Buy
534,450
+286,930
+116% +$2.16M 0.11% 192
2015
Q1
$2.1M Sell
247,520
-81,682
-25% -$696K 0.06% 212
2014
Q4
$3.06M Sell
329,202
-29,377
-8% -$255K 0.09% 185
2014
Q3
$2.99M Sell
358,579
-2,493
-0.7% -$23.1K 0.09% 184
2014
Q2
$4.17M Sell
361,072
-65,178
-15% -$669K 0.12% 173
2014
Q1
$5.41M Buy
+426,250
New +$5.51M 0.15% 172

Other funds holding DSCI

Granahan Investment Management's DSCI Position: Q1 2017 in Review

Granahan Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 1,148,970 shares — an estimated $5.97M sold.

Granahan Investment Management first reported a position in DSCI in Q1 2014 and held it in 12 quarters. The position peaked at $5.97M in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Granahan Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Granahan Investment Management sold 1,148,970 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $5.97M.
  • Granahan Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 12 quarters.
  • Granahan Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $5.97M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Granahan Investment Management's 13F filing for Q1 2017, filed 15 May 2017.